Why won't my peptide dissolve in plain water?

Peptides with more than 50% hydrophobic residues lack sufficient charge to interact with water. Try an acidic diluent (1-10% acetic acid) for basic sequences or a basic diluent (1% ammonium hydroxide) for acidic ones. DMSO followed by dropwise dilution into aqueous buffer works for most remaining cases.

Can I use DMSO with any peptide?

No. Cysteine and methionine residues are oxidized by DMSO, causing degradation before the solution reaches the assay. For peptides containing either residue, use dilute acetic acid or a buffer with a mild reducing agent. For all other sequences, DMSO below 5% v/v in the final solution is generally acceptable for biochemical assays.

What is the GRAVY score and how is it calculated?

GRAVY (Grand Average of Hydropathy) is the arithmetic mean of Kyte-Doolittle hydropathy values across all residues in a sequence. Negative values predict aqueous solubility; positive values indicate likely hydrophobicity. ExPASy ProtParam calculates it from a pasted sequence in seconds.

Should I use TFA or acetic acid for dissolving basic peptides?

Both work. TFA at 0.1% gives consistent pH and is standard in HPLC-grade applications. Acetic acid at 1-10% is less aggressive and easier to remove by lyophilization if needed later. For most bench research, acetic acid is the simpler choice. TFA is preferred when downstream mass spectrometry requires ion-pairing reagent compatibility.

How long is a reconstituted peptide solution stable?

At -70 degrees C in single-use aliquots, most peptides are stable for one year or more. Working solutions at 1-100 pmol/uL stored at -20 degrees C are typically usable for three months. At room temperature or in a standard refrigerator, degradation is measurable within 24-72 hours for many sequences. Tropical ambient temperatures shorten this window further.

Does freezing a reconstituted peptide damage it?

A single freeze-thaw cycle has minimal effect on most peptides. Repeated cycles cause cumulative degradation through hydrolysis and oxidation. The standard practice is to aliquot into single-use volumes before the first freeze so each aliquot is thawed exactly once.

Peptide solubility: diluent selection guide

Peptide solubility is determined by amino acid composition, net charge at working pH, and the diluent chosen for reconstitution. Choosing the wrong diluent produces a turbid, aggregated solution that wastes material and gives unreliable assay results.

What controls peptide solubility in water

Solubility is governed by competition between polar, charged side chains that interact favorably with water and hydrophobic side chains that cluster together and exclude it. A 2018 simulation study in the Journal of Physical Chemistry B (Sarma, Wong, Lynch, and Pettitt; 7 pentapeptide variants; PMID 29384681) computed the solubility limit of pentapeptides by modeling phase separation in oversaturated aqueous solutions. The residue solubility rank order the authors derived -- Arg > Asp > Gly > Val > Gln > Asn > Phe -- matched experimentally measured single amino acid solubilities, confirming that side-chain chemistry is the dominant variable.

The same study found that backbone carbonyl-carbonyl (CO-CO) interactions contributed more to aggregation than inter-residue hydrogen bonds. This matters for longer peptides: even a sequence with moderate hydrophobicity can aggregate if its backbone geometry creates favorable CO-CO contact geometry.

Net charge at working pH follows directly from side-chain composition. Peptides with more than 25% charged residues (Arg, Lys, His, Asp, Glu) and fewer than 25% hydrophobic residues typically dissolve in water or aqueous buffer without additional manipulation. Peptides with more than 50% hydrophobic residues usually need an organic co-solvent or a pH-adjusted diluent.

Predicting solubility before opening the vial

Two minutes of sequence analysis before opening a vial saves considerably more time than multiple failed dissolution attempts.

Residues that favor aqueous solubility include Arg (R), Lys (K), His (H), Asp (D), Glu (E), Ser (S), Thr (T), Asn (N), and Gln (Q). Residues that reduce it include Ala (A), Val (V), Ile (I), Leu (L), Met (M), Phe (F), Trp (W), and Pro (P). Cys (C) is treated separately: it can form disulfide bonds and reacts poorly with DMSO.

A practical benchmark: if at least 1 in 5 residues carries a charge at working pH, the peptide will typically dissolve in water at concentrations between 1 and 10 mg/mL. The GRAVY score (Grand Average of Hydropathy, calculated as the sum of Kyte-Doolittle hydropathy values divided by sequence length) formalizes the same principle. Negative GRAVY values favor aqueous dissolution; positive values indicate sequences that need solvent support. ExPASy ProtParam calculates GRAVY from a pasted sequence in seconds.

For compounds in the catalog, the amino acid sequence is listed on each compound page. That sequence is the starting point for this analysis.

Diluent options by peptide class

Three categories of diluent cover the majority of research peptides. Start with the simplest option and work toward more complex co-solvent systems only if the simpler approach fails.

Aqueous diluents

Water, phosphate-buffered saline (PBS), and bacteriostatic water work for peptides with net charge and low hydrophobic content. Use a test volume of 0.1 to 0.5 mL per mg of peptide and check for clarity after five minutes. If the solution is clear with no particulates, proceed to full target volume. The full bacteriostatic water reconstitution protocol covers the stepwise procedure for standard lyophilized research vials.

Acidic and basic diluents

Basic peptides with high Arg, Lys, or His content that do not dissolve in pure water often respond to 1 to 10% glacial acetic acid in water (v/v) or 0.1% trifluoroacetic acid (TFA). These acidic diluents protonate the basic side chains, increasing the net positive charge and improving interaction with water. Acidic peptides with high Asp or Glu content benefit from the opposite approach: 1% ammonium hydroxide or 50 mM ammonium bicarbonate at pH 7 to 8 deprotonates the acid side chains and reduces peptide-peptide aggregation driven by hydrophobic patches.

In both cases, use the acidic or basic diluent only for the initial dissolution step. Once the peptide is fully dissolved in a small volume of the adjusted solvent, dilute further with water or neutral buffer to reach working concentration and check the final pH if the assay is pH-sensitive.

Organic co-solvents

DMSO is the most widely used co-solvent for poorly soluble peptides in research settings. The procedure is to dissolve the dry peptide fully in neat DMSO first (10 to 20 uL per mg of peptide), then add the DMSO stock dropwise to the aqueous buffer while mixing. Final DMSO concentration should stay below 5% v/v for biochemical assays. For cell-based work, most protocols cap it at 0.5 to 1% to avoid cytotoxicity artifacts.

Acetonitrile (ACN) is an alternative with distinct solvation properties. A 2019 molecular dynamics study in the Journal of Molecular Graphics and Modelling (PMID 30831385; Ace-Gly-X-Gly-Nme model peptides) compared DMSO and ACN as co-solvents and found they cause different conformational perturbations depending on the central residue identity. DMSO affects kinetic stability of helix-compatible conformations differently than ACN affects beta-sheet-favoring geometries. For most routine solubility problems, the conformational distinction is secondary to achieving dissolution -- but it is relevant in structure-activity studies or conformation-dependent binding assays.

One firm restriction applies regardless of solubility class: peptides containing Cys or Met must not use DMSO as the primary solvent. DMSO oxidizes free thiols on Cys and the thioether sulfur on Met, causing chemical degradation before the solution reaches the assay. Use dilute acetic acid or an aqueous buffer with a mild reducing agent (e.g., dithiothreitol at 1 mM) for these sequences instead.

DMF (dimethylformamide) appears as a co-solvent in older literature but is a poor choice in biological research due to toxicity at the concentrations required. DMSO or ACN are preferred in current practice.

Step-by-step protocol for difficult peptides

This sequence is consistent with the handling recommendations published by the NCI Clinical Proteomic Tumor Analysis Consortium (Hoofnagle et al., Clinical Chemistry, 2016, 62(1):48-69; PMC4830481):

Let the sealed vial warm to room temperature before opening. This prevents condensation from entering the dry powder.
For a hydrophobic peptide, add 10 to 20 uL of neat DMSO per mg of dry peptide. Vortex, then sonicate in a bath sonicator for 30 to 60 seconds until the solution is clear.
Add aqueous buffer (PBS or sterile water) dropwise to the DMSO solution while mixing, keeping final DMSO below 5% v/v.
If turbidity persists after the dropwise addition, bath-sonicate for another 1 to 2 minutes at room temperature before switching strategy.
For Cys- or Met-containing peptides, substitute 10% acetic acid (v/v) in water for DMSO in step 2, then dilute into aqueous buffer.

Use the dosing calculator to work out the exact DMSO stock volume needed to hit your target concentration before adding aqueous buffer.

Once dissolved, prepare concentrated stock aliquots at 0.5 to 2 nmol/uL and store at -70 degrees C or below. The NCI consortium recommendations treat this as the minimum threshold for long-term stability beyond six months. Working solutions at 1 to 100 pmol/uL stored at -20 degrees C are stable for up to three months. Freeze-thaw cycles degrade peptide integrity through cumulative hydrolysis and oxidation; single-use aliquots prepared at the time of first reconstitution eliminate this problem.

Storage and handling in tropical climates

Indonesia's ambient temperatures above 30 degrees C and relative humidity routinely exceeding 80% introduce two risks that standard temperate-climate protocols do not account for. First, reconstituted peptide solutions left outside cold storage degrade faster than published stability data suggests. Most stability figures in the literature come from laboratories operating at 20 to 22 degrees C with controlled humidity. A reconstituted vial at tropical room temperature is in a meaningfully different condition.

Second, condensation forms inside improperly sealed vials when they are moved between cold storage and warm ambient air. Moisture entering dry lyophilized powder before controlled reconstitution can initiate hydrolysis of acid-labile bonds, particularly in sequences containing Asp-Pro or Asn-Gly motifs. Letting the sealed vial equilibrate to room temperature before opening is not optional in this climate -- it is the step that prevents moisture contamination.

The lyophilized peptide storage guide covers specific temperature targets, humidity-controlled storage options, and the practical differences between household refrigeration and proper -20 degrees C freezer storage in a Bali or Jakarta research context.

Peptide solubility in research protocols+